Skip to main content
SpringerLink
Log in

First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients

  • Letter to the Editor
  • Published:
Molecular Psychiatry Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Coyle JT, Tsai G, Goff D . Ann NY Acad Sci 2003; 1003: 318–327.

  2. Erlandsson K, Bressan RA, Mulligan RS, Gunn RN, Cunningham VJ, Owens J et al. Nucl Med Biol 2003; 30: 441–454.

  3. Stone J, Erlandsson K, Arstad E, Bressan RA, Teneggi V, Ell PJ et al. Schizophrenia Bull 2005; 31 (2): 446.

  4. Bressan RA, Erlandsson K, Stone JM, Mulligan RS, Krystal JH, Ell PJ et al. Biol Psychiatry 2005; 58 (1): 41–46.

  5. Friston K, Holmes A, Worsley K, Poline J, Frith C, Frackowiak RSJ . Human Brain Mapping 1995; 2: 189–210.

  6. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L et al. Human Brain Mapping 2000; 10: 120–131.

  7. Takeuchi R, Yonekura Y, Matsuda H, Konishi J . Eur J Nucl Med Mol Imaging 2002; 29: 331–341.

Download references

Acknowledgements

RA Bressan was financially supported by research grants from CAPES (Brazil), Janssen Pharmaceutica Inc., and Sanofi-Syntelabo, LS Pilowsky was financially supported by a UK Medical Research Council (MRC) Senior Clinical Research Fellowship. K Erlandsson and RS Mulligan were financially supported on a UK MRC Senior clinical research fellowship. JH Krystal was funded by NIH: KO5 AA 014906-02, Department of Veterans Affairs: VA Alcohol Research Center, VA Schizophrenia Biological Research Center. LSP, RAB, JMS, KE, RSM, PJE contributed to the study execution, analysis and writing up of the data. JHK contributed to the interpretation and writing up of the data.

Author information

Authors and Affiliations

  1. King's College London, Institute of Psychiatry, London, UK

    L S Pilowsky, R A Bressan & J M Stone

  2. Institute of Nuclear Medicine, University College London, London, UK

    L S Pilowsky, K Erlandsson, R S Mulligan & P J Ell

  3. Department of Psychiatry, Yale University, New Haven, CT, USA

    J H Krystal

  4. VA Connecticut Healthcare System, West Haven, CT, USA

    J H Krystal

Authors
  1. L S Pilowsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R A Bressan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J M Stone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Erlandsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R S Mulligan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J H Krystal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P J Ell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pilowsky, L., Bressan, R., Stone, J. et al. First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol Psychiatry 11, 118–119 (2006). https://doi.org/10.1038/sj.mp.4001751

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001751

  • Springer Nature Limited

This article is cited by

Search

Navigation